文献速递甲状腺与颈部外科围术期管理与 ERAS

甲状旁腺切除术对原发性甲状旁腺功能亢进患者抑郁症状的影响:系统综述与荟萃分析

Impact of parathyroidectomy on depression symptoms in patients with primary hyperparathyroidism: A systematic review and meta-analysis.
PubMed 文献 · Surgery · 2025-05-31

该系统综述与荟萃分析纳入26项来自11个国家的研究、共2365例原发性甲状旁腺功能亢进患者,评估甲状旁腺切除术后抑郁症状变化。荟萃分析显示术后短期(≤3个月)抑郁评分显著改善(效应估计=0.57;95%CI 0.33-0.81),中期(3-12个月)无一致改善证据(效应估计=0.68;95%CI -0.32至1.69),长期(>12个月)抑郁评分显著且一致降低(效应估计=0.46;95%CI 0.21-0.71)。

要点

  • 原发性甲状旁腺功能亢进患者诊断时常伴抑郁症状,应关注心理健康评估。
  • 甲状旁腺切除术后短期抑郁评分显著改善,长期获益持续存在。
  • 术后3-12个月中期抑郁改善证据不一致,需个体化随访评估。

核心结论

  • 原发性甲状旁腺功能亢进患者诊断时常见抑郁症状,甲状旁腺切除术后短期和长期抑郁评分显著降低,手术提供持久心理健康获益。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane Library和SciELO数据库,纳入2000年至今相关文献,遵循PRISMA策略。
  • 共纳入26项来自11个国家的研究,总样本2365例甲状旁腺功能亢进患者,使用12种抑郁症状测量工具。
  • 对使用两种最常见抑郁特异性问卷的研究进行荟萃分析。

主要发现

  • 短期(术后≤3个月)抑郁评分显著改善,效应估计=0.57(95%CI 0.33-0.81),但研究间异质性明显。
  • 中期(术后3-12个月)抑郁改善无一致证据,效应估计=0.68(95%CI -0.32至1.69)。
  • 长期(术后>12个月)抑郁评分显著且一致降低,效应估计=0.46(95%CI 0.21-0.71)。

临床怎么用

  • 对原发性甲状旁腺功能亢进患者应评估抑郁症状,甲状旁腺切除术可能带来短期及长期心理健康改善。
  • 术后中期抑郁改善证据不一致,需在3-12个月期间关注症状变化并个体化随访。

局限性

  • 短期改善结果存在显著研究间异质性。
  • 中期评估未显示一致改善证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The presentation of primary hyperparathyroidism has evolved in recent years. At the moment, most patients are diagnosed incidentally through routine tests. However, these patients may present depressive symptoms and mood disturbances that may affect their quality of life. The objective of this study was to analyze published articles that evaluate depressive symptoms in patients with primary hyperparathyroidism and the changes produced in the short, mid, and long term after parathyroidectomy. METHODS: A systematic review of the literature on published articles that evaluated the role of parathyroidectomy on symptoms related to depression in primary hyperparathyroidism was carried out. A search was conducted in PubMed, Cochrane Library, and SciELO databases using terms specifically related to depression. All relevant literature published from the year 2000 to the present was included. The selection of studies was guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses strategy. A meta-analysis was performed with studies that used the 2 most common depression-specific questionnaires. RESULTS: In total, 26 studies conducted in 11 different countries were included. A total population of 2,365 patients with hyperparathyroidism was collected and a total of 12 measurement instruments, specific and general, for depressive symptoms were used. The meta-analysis revealed a significant short-term (up to 3 months postoperatively) improvement in depression scores after surgery (effect estimate = 0.57; 95% confidence interval [CI], 0.33-0.81), though with notable heterogeneity among studies. Mid-term assessments (between 3 and 12 months postoperatively) did not show consistent evidence of improvement (effect estimate = 0.68; 95% CI, -0.32 to 1.69). However, long-term analysis (beyond 12 months postoperatively) demonstrated a significant and consistent reduction in depression scores (effect estimate = 0.46; 95% CI, 0.21-0.71) across studies. CONCLUSION: Patients with primary hyperparathyroidism often present with depressive symptoms at diagnosis. Following parathyroidectomy, a significant improvement in these symptoms is observed. The meta-analysis confirms marked reductions in depression scores shortly after surgery, with these benefits sustained over the long term. Overall, the surgery provides lasting mental health benefits.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Ruiz-Manzanera JJ, Febrero B, López-López JA, et al. Impact of parathyroidectomy on depression symptoms in patients with primary hyperparathyroidism: A systematic review and meta-analysis. Surgery. 2025. PMID: 40450813. doi:10.1016/j.surg.2025.109461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。